TCG Crossover Management »

Rayzebio shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Rayzebio shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Rayzebio

Tip: Access up to 7 years of quarterly data

All positions including Rayzebio held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rayzebio by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $19M 870k 22.20

More positions owned by TCG Crossover Management

Structure Therapeutics Adrs (GPCR)
Cogent Biosciences Comm (COGT)
Geron Corp Comm (GERN)
AN2 Therapeutics Comm (ANTX)
Savara Comm (SVRA)
Taysha Gene Therapies Comm (TSHA)
Kalvista Pharmaceuticals Comm (KALV)
Inhibrx Comm (INBX)
Aerovate Therapeutics Comm (AVTE)
Icosavax Comm
Compass Pathways Adrs (CMPS)
Ventyx Biosciences Comm (VTYX)
Tyra Biosciences Comm (TYRA)
Madrigal Pharmaceuticals Comm (MDGL)
Silence Therapeutics Adrs (SLN)

View all positions for TCG Crossover Management

Top funds holding Rayzebio

Wellington Management Company
Hillhouse Capital Advisors
Alliancebernstein
ALPS Advisors
Allianz Asset Management
Teachers Retirement System Of The State Of Kentucky
Kellner Capital
MetLife Investment Advisors
American International
Metropolitan Life Insurance Company

View all funds holding Rayzebio